Clinical Trials for San Rocco Therapeutics

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: San Rocco Therapeutics

Clinical Trials (1)

NCT01639690
ß-Thalassemia Major with Autologous CD34+ Hematopoietic Progenitor Cells Transduced with TNS9.3.55 a Lentiviral Vector Encoding the Normal Human ß-Globin Gene
PHASE1Active, not recruiting
10 participants
Started: Jul 31, 2012 · Completed: Jul 31, 2025
1 condition1 sponsor1 location